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ABSTRACT
This study presents a critical evaluation of the scientific literature related to 
this subject, aiming to assess the policies and administrative issues regarding 
the prevention and magnitude of healthcare-associated infections and discuss 
the challenges for their prevention in Brazil. The topics discussed included 
historical and administrative issues, challenges imposed by the characteristics 
of the healthcare system and the territorial dimension, laboratorial support 
limitations, costs, institutional culture, professional qualification, and patient 
engagement. It is urgent to hold a nationwide discussion among government 
representatives, institutions, and healthcare workers and users to overcome 
these challenges.
DESCRIPTORS: Cross Infection, prevention & control. Hospital 
Infection Control. Program Housekeeping, Hospital. Infectious 
Disease Transmission, Patient-to-Professional. Infectious Disease 
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Healthcare-associated infections (HAI) were first diag-
nosed during the so-called “Pasteur revolution” by 
investigators including Ignaz Semmelweis, Florence 
Nightingale, and Joseph Lister.6 During the 21st century, 
because of the development of increased life support 
and immunosuppressant therapies, the need to control 
hospital-acquired infections became apparent. Therefore, 
hospital-acquired infections have been systematically 
addressed in developed countries.10,15 Since the mid-
1990s, the term “hospital infection” was replaced with 
the term “HAI”; the latter designation is a broad concept 
that incorporates infections that are acquired and associ-
ated with healthcare activities in any given environment.4
HAI have a great impact upon hospital mortality, dura-
tion of hospitalization, and costs. The growing number 
of conditions that lead to hospitalization of individuals 
presenting with increasingly severe clinical conditions 
and immunosuppression, in addition to the increased resis-
tance to antimicrobial agents, indicates the importance of 
HAI in public health management. In addition, developing 
countries suffer from a large number of HAI, which can 
be 20 times larger than that observed in developed coun-
tries.2,13 The factors associated with the lack of qualified 
human resources, along with an inadequate physical struc-
ture for healthcare services and limited knowledge of  HAI 
control measures, contribute to this scenario.
RESUMO
Objetivou-se apresentar os principais marcos históricos e regulatórios da prevenção das 
infecções relacionadas à assistência em saúde, a magnitude do problema no Brasil e uma 
visão crítica sobre os desafios e necessidades para sua prevenção no País. Assim, foi 
desenvolvida narrativa crítica sobre infecções relacionadas à assistência à saúde quanto 
aos elementos normativos e administrativos da prevenção, da magnitude do fenômeno, 
apontando desafios para o controle de tais infecções no Brasil. São discutidos aspectos 
históricos do controle de infecções relacionadas à assistência à saúde, as dificuldades 
impostas pelas características do sistema de saúde e dimensões geográficas do País, as 
limitações de suporte laboratorial, custos, cultura institucional, capacitação de profissionais e 
engajamento dos pacientes. Considerou-se premente haver discussão nacional sobre o tema 
por meio do diálogo entre os segmentos da representação governamental, das instituições, 
dos trabalhadores e usuários do sistema de saúde, para superação desses desafios.
DESCRITORES: Infecção Hospitalar, prevenção & controle. Programa 
de Controle de Infecção Hospitalar. Serviço Hospitalar de Limpeza. 
Transmissão de Doença Infecciosa do Paciente para o Profissional. 
Transmissão de Doença Infecciosa do Profissional para o Paciente. 
Vigilância Sanitária. Vigilância Epidemiológica.
INTRODUCTION
After acknowledging that HAI are a public health problem, 
the World Health Organization (WHO) recommended 
that health authorities designate an agency to manage a 
nationwide healthcare program, which should be aligned 
with other healthcare goals.a In Brazil, the discussions on 
programmatic actions are essential to acknowledge the 
advances made to date, identify challenges, and propose 
strategies to amplify the potential of these actions.
The present study aimed to investigate the historical 
and regulatory milestones for the prevention of HAI, to 
recognize the magnitude of the problem, and to make a 
critical assessment of the challenges and needs for the 
prevention of HAI in Brazil.
Historical and regulatory milestones related to 
HAI in Brazil
Although the first HAI Prevention and Control 
Committee (HAIPCC) appeared in the 1960s, the 
programmatic and governmental actions only began 
at the end of the military dictatorship by norms estab-
lished by the Brazilian Ministry of Health (MoH).b In 
the 1980s, several national technical guidelines involving 
the assessment of healthcare facilities were published, 
when the use of epidemiological methods to deal with 
HAI was still in its infancy. In addition, in this period, this 
a World Health Organization. Practical guidelines for infection control in healthcare facilities. Geneva; 2004 [cited 2012 Dec 4]. Available 
from: http://www.wpro.who.int/publications/docs/practical_guidelines_infection_control.pdf
b Brasil. Lei nº 9.431, de 6 de Janeiro de 1997. Dispõe sobre a obrigatoriedade de manutenção de programas de controle de infecção 
hospitalar pelos hospitais do país. Diario Oficial Uniao. 7 jan 1997:265.
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subject was discussed among various health authorities, 
and MoH implemented a training program focused on the 
training of 14,000 healthcare professionals.5 However, 
the impact of this initiative was not assessed, and the 
project was discontinued. This initiative was followed 
by a gap in terms of government training activities, and 
only in 2004, new training programs were offered to 
health surveillance professionals via distance learning.3
A Regional Conference on Prevention and Control of 
HAI was held in 1990 and emphasized the need to imple-
ment national HAI prevention and control committees.c 
In Brazil, this committee was established by the imple-
mentation of the National HAI Prevention and Control 
Program (NHAICP),c which resulted in the creation of 
the Divisão Nacional de Controle de Infecção Hospitalar 
(National Division of HAI Control).1 A few reports on 
the effective actions performed by this division are 
available, and a new national committee was imple-
mented only 20 years later (Table). The following other 
directives were created during this regional confer-
ence: (a) binding hospital accreditation to the establish-
ment of HAI programs; (b) inclusion of the topic in the 
health sciences curriculum and in continued education 
programs; (c) cooperation between state institutions 
and universities for the development of epidemiological 
research; (d) identification of regional reference micro-
biology laboratories; and (e) implementation of working 
groups focused on the use of antimicrobial agents and 
microbiological diagnosis of HAI. Despite the many 
advances in this sector, the recommendations established 
in this conference were not achieved.
At present, the legislation that determines the general 
guidelines for the prevention and control of HAI are 
Law 9,431 (1997),b Ordinance 2,616 (1998),d and 
Resolution RDC 48 (2000).e The key element of these 
guidelines is the requirement to implement HAIPCC 
in hospitals. Ordinance 2,616 introduced the proposal 
to develop structured programs at the federal, state, 
and municipal levels. However, there was heteroge-
neity in the state coordination for the control of HAI, 
and improvement in this scenario was one of the main 
proposals of NHAICP since the beginning of 2000.f
From 2000, PNCIH linked with the National Health 
Surveillance Agency (ANVISA), which promotes the 
interface with other health surveillance (Table). The 
transfer of the National HAI Program to ANVISA was 
an emblematic hallmark and indicated that at the federal 
government level, the management of HAI should be 
maintained within the sphere of sanitary audit. Unlike 
other public health problems, HAI have been perceived 
as a problem that requires normalization and auditing. 
The results of this approach were ambiguous. On one 
hand, there was a notable improvement in the legislation 
applied for the prevention of HAI and increased health 
surveillance. On the other hand, the control of HAI was 
perceived as an activity focused on compliance to stan-
dards and solely related to the attitude of individual health-
care services under the law. This weakened the perception 
of HAI control as a public health problem or shifted the 
collective perspective about the problem. This factor partly 
contributed to the initial failure of the attempts made to 
quantify the impact of this strategy nationwide.
The regulatory role of ANVISA has been intensive since 
its inception. The regulation of marketed products such as 
sanitation and healthcare products (including equipment) 
is one of the strongest areas, along with the normalization 
of physical areas for healthcare services (Table). In recent 
years, the creation of guidelines has intensified; until 2012, 
10 guidelines were already available in ANVISA’s website.g
The recent history of HAI control in Brazil has suffered 
the impact of large-scale epidemics. The outbreaks of 
rapidly growing mycobacteria in invasive proceduresh 
have shed light on important failures in the reprocessing 
of articles, aggravated by the detection of resistance 
of rapidly growing mycobacteria resistant to glutaral-
dehyde.7-9,11 In addition, outbreaks of carbapenemase-
producing Klebsiella pneumoniae and Enterococcus spp. 
resistant to vancomycini were widely covered by the press, 
culminating in the prohibition of purchase of antimicro-
bial agents without medical prescription and the obliga-
tory use of alcohol-based disinfectants in healthcare units 
(Table). With regard to laboratory support and manage-
ment of microbial resistance, board committees composed 
of specialists were created; however, to date, their actions 
are scarce, considering the extent of the problem (Table).
In 2007, in line with the development of global strategies 
for the prevention of HAI, MoH officially engaged in 
the Global Patient Safety Initiative proposed by WHO. 
c Santos AAM. O modelo brasileiro para o controle das infecções hospitalares após vinte anos de legislação, onde estamos e para onde 
vamos? [master’s dissertation]. Belo Horizonte: Faculdade de Medicina da UFMG; 2006.
d Ministério da Saúde. Portaria nº 2.616, de 12 de maio de 1998. Diario Oficial Uniao. 13 maio 1998;Seção1;133.
e Agência Nacional de Vigilância Sanitária. Roteiro de inspeção do programa de controle de infecção hospitalar. RDC nº 48, de 2 de junho de 
2000. Diario Oficial Uniao. 6 jul 2000;Seção I:1415.
f Sociedade Brasileira de Infectologia. São Paulo; 2014 [cited 2012 Nov 5]. Available from: http://www.sbinfecto.org.br
g Agência Nacional de Vigilância Sanitária. Segurança do paciente e qualidade em serviços de saúde. Bol inform Segur Pac Qual Serv Saude. 
2011 [cited 2013 Feb 2];I(1):1-12. Available from: http://portal.anvisa.gov.br/wps/wcm/connect/f72c20804863a1d88cc88d2bd5b3ccf0/
BOLETIM+I.PDF?MOD=AJPERES
h Agência Nacional de Vigilância Sanitária. Relatório descritivo de investigação de casos de infecções por micobactérias não tuberculosas de 
crescimento rápido (MCR) no Brasil no período de 1998 a 2009. Brasília (DF); 2011 [cited 2011 Nov 25]. Available from: http://www.anvisa.
gov.br/hotsite/hotsite_micobacteria/relatorio_descrito_mcr_16_02_11.pdf
i Agência Nacional de Vigilância Sanitária. Investigação e controle de bactérias multiresistentes. Brasília (DF); 2007 [cited 2012 Nov 3]. 
Available from: http://www.anvisa.gov.br/servicosaude/controle/reniss/manual%20_controle_bacterias.pdf
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However, most of these actions have been implemented 
by ANVISA, with the recent involvement of MoH.g
Magnitude of the HAI problem in Brazil
To date, the only known national assessment performed 
in Brazil is that by Prade et al (1995), wherein a HAI 
prevalence of 15.0% was found in 99 tertiary hospitals.14
After 2001, ANVISA started assessing situation of HAI 
programs in Brazilian hospitals.j The findings underscored 
structural fragilities in HAI control: 1/3 of the hospitals did 
not have microbiology laboratory support. This fragility 
in the Northeast (46.0%) was accentuated compared 
with that in the Southeast (24.0%).c Furthermore, essen-
tial requirements were not met by all institutions, such as 
the accreditation of CCIH (76.0%) and performance of 
epidemiological surveillance (77.0%). In 2002, a national 
survey was conducted to assess the suitability of microbi-
ology laboratories in Brazil and helped to identify perti-
nent fragilities in this area.k
Moreover, it is acknowledged that only an effec-
tive nationwide epidemiological surveillance system 
could define the real magnitude of the HAI problem 
in Brazil.10 The first surveillance systems created at 
the governmental level that achieved concrete results 
occurred in the states of Sao Paulo and Paraná.12,16
From 1998, the overall understanding of programmatic 
actions began to incorporate the epidemiological manage-
ment of HAI. In 2010, ANVISA implemented the surveil-
lance of primary bloodstream infections associated with 
central venous catheters. The 2012 data on 1,128 hospitals 
identified an incidence of 5.5 and 2.0 for primary blood-
stream infections per 1,000 central venous catheters per 
day using laboratory and clinical data, respectively. These 
data were collected at adult intensive care units (ICU), and 
coagulase-negative Staphylococcus strains were the most 
common etiological agents.g In 2013, the National HAI 
Prevention and Control Program was launched.l
Challenges for the future of HAI prevention and 
control in Brazil
HAI monitoring by ANVISA implies a different 
approach from that used for the management of other 
health problems that are currently under the compe-
tence of the National Surveillance Department at MoH. 
In practice, there is a lack of human resources in this 
area, and no specific funding has supported the National 
HAI Prevention and Control Program.
Some major challenges include the large territory, 
presence of difficult-to-access regions, large number 
of healthcare institutions (particularly in the larger 
states and municipalities), large number of small-
sized hospitals (≤ 50 beds) with difficulty in imple-
menting CCIH, heterogeneity of healthcare services, 
and insufficient number of ICU. In addition, economic 
and cultural differences and distinct political views 
regarding HAI occur in distinct regions and hinder the 
establishment of homogeneous normative standards 
in Brazil. For example, CNES (National Registry of 
Health Institutions)m listed 6,266 hospitals in June 2012, 
distributed in a heterogeneous manner throughout the 
Brazilian territory, and more than 50.0% of them were 
located in the Southeast and South regions.
The Brazilian constitution acknowledges that health-
care is a right of every citizen and a state responsibility; 
however, it does not prohibit the creation of private 
healthcare services.n The Brazilian Unified Health 
System functions at the municipal, state, and federal 
levels by directly management or agreements or contracts 
with private healthcare units. On the other hand, the 
private sector (supplementary healthcare services) orga-
nizes itself by healthcare plans or by direct reimburse-
ment of healthcare costs to the users. Therefore, impor-
tant factors such as the dual healthcare system, imple-
mentation of alternative health management strategies, 
and decentralized management model indicate that many 
interlocutors will need to discuss prevention strategies.
The lack of reference laboratories to adequately provide 
healthcare support and the growing need of microbiolog-
ical research, particularly that aimed at providing a rapid 
response to outbreaks, are challenges that urgently need to 
be overcome. Considering that high-level microbiological 
research is being conducted at Brazilian universities, it is 
a paradox how most of these results are not being directed 
toward public health priorities in the country.
The growing health costs and limited availability of mate-
rial resources and skilled labor involved in the control of 
HAI are relevant adversities. With regard to professional 
health training, academic courses that provide training in 
this area are rare. Regardless of academic training, providing 
permanent in-service professional education is essential 
and is a challenge for governments, health institutions, and 
j Agência Nacional de Vigilância Sanitária. Diagnóstico do controle de infecção hospitalar no Brasil. Brasília (DF); 2005 [cited 2013 Feb 2]. 
Available from: http://www.anvisa.gov.br/servicosaude/controle/Infectes%20Hospitalares_diagnostico.pdf
k Agência Nacional de Vigilância Sanitária. Análise do Inquérito Nacional sobre infra-estrutura, recursos humanos, equipamentos, 
procedimentos, controle de qualidade e biossegurança nos Laboratórios de Microbiologia. Brasília (DF); 2007.
l Agência Nacional de Vigilância Sanitária. Programa Nacional de Prevenção e Controle de Infecções Relacionadas à Assistência à Saúde. 
Brasília (DF); 2013 [cited 2014 Jun 24]. Available from: http:// http://portal.anvisa.gov.br/wps/portal/anvisa/anvisa/home/servicosdesaude
m Ministério da Saúde. CNES: Cadastro Nacional dos Estabelecimentos de Saúde. Brasília (DF); 2000 [cited 2014 Jun 24]. Available from: 
www.cnes.datasus.gov.br
n Conselho Nacional de Secretários de Saúde. Legislação do SUS. Progestores 2003 - Programa de Informação e Apoio Técnico às Novas 
Equipes Gestoras Estaduais do SUS de 2003. Brasília (DF); 2003.
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healthcare workers, who should be proactive and constantly 
trained. The managers of institutions sometimes underes-
timate the magnitude of the problem, and the support for 
preventive measures is not always robust.
Despite some positive initiatives,o citizens have limited 
access to information on HAI, including the role of 
patients and family members. The press is generally 
sensationalist and frightening when addressing the 
issue of HAI. It is necessary to stimulate community 
representation on advisory committees to government 
institutions and health.
It is urgent to hold a thorough nationwide discus-
sion about what should be the concrete manifesta-
tion of the State regarding HAI prevention in Brazil. 
The dialogue between the segments of representa-
tive government, health institutions, health workers, 
and users of the system is a key element to overcome 
these challenges.
o Silva PF, Padoveze MC. Infecções relacionadas a serviço de saúde - orientações para público geral. Conhecendo um pouco mais sobre as 
precauções específicas. São Paulo: Centro de Vigilância Epidemiológica; 2012 [citado 2013 Fev 02]. Available from: http://www.cve.saude.
sp.gov.br/htm/ih/pdf/IRAS12_LEIGOS_PRECAUCAO.pdf
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